ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017
Relation Between Narrow Networks and Providers of Cancer Care.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Impact of Narrow and Tiered Networks on Costs, Access, Quality, and Patient Steering: A Systematic Review.Medical care research and review : MCRR · 2022Pooled it
- Oncology Organization and Oncologist Networks Under Medicare Advantage Plans.JAMA network open · 2026Article
- Increase in Pancreatoduodenectomy Volume at Mid-Volume Facilities in the United States: A National Cancer Database Analysis.Annals of gastroenterological surgery · 2026Article
- Impact of the Affordable Care Act on access to accredited facilities for cancer treatment.Health services research · 2024Article
- Composition of buprenorphine prescribing networks in Medicaid and association with quality of care.Journal of substance use and addiction treatment · 2024Observational
- Association between a network-based physician linchpin score and cancer patient mortality: a SEER-Medicare analysis.Journal of the National Cancer Institute · 2024Article
- Characteristics of Specialty Mental Health Provider Networks in Oregon Medicaid.Psychiatric services (Washington, D.C.) · 2023Article
- Spatial-Temporal Trends in Ovarian Cancer Outcomes in California.JNCI cancer spectrum · 2022Article
- Variation in network adequacy standards in Medicaid managed care.The American journal of managed care · 2022Article
- Comparison of the use of the top-ranked cancer hospitals between Medicare Advantage and traditional Medicare.The American journal of managed care · 2021Article
- Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.JAMA network open · 2021Article
- Regulation of provider networks in response to COVID-19.The American journal of managed care · 2021Article
- State Standards for Insurance Access to Oncologists.JNCI cancer spectrum · 2021Article
- Provider networks and health plan premium variation.Health services research · 2021Article
- Comparison of Office-Based Physician Participation in Medicaid Managed Care and Health Insurance Exchange Plans in the Same US Geographic Markets.JAMA network open · 2020Article
- Insurance Networks and Access to Affordable Cancer Care.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Review
- Motivators, Barriers, and Facilitators to Traveling to the Safest Hospitals in the United States for Complex Cancer Surgery.JAMA network open · 2018Article
- The Affordable Care Act and Adolescents and Young Adults With Cancer: Much Progress, but Challenges Remain.JAMA oncology · 2018Article
- Quality Regulation? Access to High-Quality Specialists for Medicare Advantage Beneficiaries in California.Health services research and managerial epidemiologyArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
Purpose Health insurers offer plans covering a narrow subset of providers in an attempt to lower premiums and compete for consumers. However, narrow networks may limit access to high-quality providers, particularly those caring for patients with cancer. Methods We examined provider networks offered on the 2014 individual health insurance exchanges, assessing oncologist supply and network participation in areas that do and do not contain one of 69 National Cancer Institute (NCI)-Designated Cancer Centers. We characterized a network's inclusion of oncologists affiliated with NCI-Designated Cancer Centers relative to oncologists excluded from the network within the same region and assessed the relationship between this relative inclusion and each network's breadth. We repeated these analyses among networks offered in the same regions as the subset of 27 NCI-Designated Cancer Centers identified as National Comprehensive Cancer Network (NCCN) Cancer Centers. Results In regions containing NCI-Designated Cancer Centers, there were 13.7 oncologists per 100,000 residents and 4.9 (standard deviation [SD], 2.8) networks covering a mean of 39.4% (SD, 26.2%) of those oncologists, compared with 8.8 oncologists per 100,000 residents and 3.2 (SD, 2.1) networks covering on average 49.9% (SD, 26.8%) of the area's oncologists ( P < .001 for all comparisons). There was a strongly significant correlation ( r = 0.4; P < .001) between a network's breadth and its relative inclusion of oncologists associated with NCI-Designated Cancer Centers; this relationship held when considering only affiliation with NCCN Cancer Centers. Conclusion Narrower provider networks are more likely to exclude oncologists affiliated with NCI-Designated or NCCN Cancer Centers. Health insurers, state regulators, and federal lawmakers should offer ways for consumers to learn whether providers of cancer care with particular affiliations are in or out of narrow provider networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.